Market Closed -
Other stock markets
|
After market 11:22:27 pm | |||
24.87 EUR | -4.88% | 24.87 | -0.01% |
05:08pm | European Equities Traded in the US as American Depositary Receipts Decrease Friday | MT |
19/09 | STMICRO : UBS remains its Buy rating | ZD |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 9.53B | 10.18B | 12.73B | 16.08B | 17.24B | |||||
Other Revenues, Total | 27M | 38M | 32M | 45M | 47M | |||||
Total Revenues | 9.56B | 10.22B | 12.76B | 16.13B | 17.29B | |||||
Cost of Goods Sold, Total | 5.86B | 6.43B | 7.44B | 8.5B | 8.98B | |||||
Gross Profit | 3.7B | 3.79B | 5.32B | 7.63B | 8.3B | |||||
Selling General & Admin Expenses, Total | 1.11B | 1.12B | 1.33B | 1.46B | 1.65B | |||||
R&D Expenses | 1.5B | 1.55B | 1.76B | 1.9B | 2.09B | |||||
Other Operating Expenses | -96M | -223M | -158M | -160M | -56M | |||||
Other Operating Expenses, Total | 2.51B | 2.45B | 2.93B | 3.2B | 3.68B | |||||
Operating Income | 1.18B | 1.34B | 2.39B | 4.43B | 4.62B | |||||
Interest Expense, Total | -54M | -54M | -42M | -13M | -55M | |||||
Interest And Investment Income | 55M | 34M | 13M | 71M | 226M | |||||
Net Interest Expenses | 1M | -20M | -29M | 58M | 171M | |||||
Income (Loss) On Equity Invest. | 1M | 2M | - | - | - | |||||
Currency Exchange Gains (Loss) | 1M | 8M | 7M | 15M | 5M | |||||
Other Non Operating Income (Expenses) | - | -26M | -43M | - | - | |||||
EBT, Excl. Unusual Items | 1.19B | 1.31B | 2.32B | 4.5B | 4.8B | |||||
Restructuring Charges | 2M | -7M | -1M | - | - | |||||
Gain (Loss) On Sale Of Investments | - | - | - | - | - | |||||
Gain (Loss) On Sale Of Assets | 7M | 14M | 5M | 2M | 6M | |||||
Asset Writedown | -7M | -4M | -1M | -38M | -42M | |||||
Legal Settlements | -1M | -11M | -10M | -8M | -12M | |||||
Other Unusual Items | - | -32M | 21M | 25M | 12M | |||||
EBT, Incl. Unusual Items | 1.19B | 1.27B | 2.34B | 4.49B | 4.76B | |||||
Income Tax Expense | 156M | 159M | 331M | 520M | 541M | |||||
Earnings From Continuing Operations | 1.03B | 1.11B | 2.01B | 3.97B | 4.22B | |||||
Net Income to Company | 1.03B | 1.11B | 2.01B | 3.97B | 4.22B | |||||
Minority Interest | -1M | -2M | -6M | -6M | -11M | |||||
Net Income - (IS) | 1.03B | 1.11B | 2B | 3.96B | 4.21B | |||||
Net Income to Common Incl Extra Items | 1.03B | 1.11B | 2B | 3.96B | 4.21B | |||||
Net Income to Common Excl. Extra Items | 1.03B | 1.11B | 2B | 3.96B | 4.21B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 1.15 | 1.24 | 2.21 | 4.37 | 4.66 | |||||
Basic EPS - Continuing Operations | 1.15 | 1.24 | 2.21 | 4.37 | 4.66 | |||||
Basic Weighted Average Shares Outstanding | 894M | 895M | 904M | 906M | 904M | |||||
Net EPS - Diluted | 1.14 | 1.2 | 2.16 | 4.19 | 4.46 | |||||
Diluted EPS - Continuing Operations | 1.14 | 1.2 | 2.16 | 4.19 | 4.46 | |||||
Diluted Weighted Average Shares Outstanding | 904M | 920M | 925M | 946M | 944M | |||||
Normalized Basic EPS | 0.83 | 0.91 | 1.6 | 3.1 | 3.31 | |||||
Normalized Diluted EPS | 0.82 | 0.89 | 1.56 | 2.97 | 3.16 | |||||
Dividend Per Share | 0.17 | 0.24 | 0.24 | 0.24 | 0.36 | |||||
Payout Ratio | 20.74 | 15.19 | 10.25 | 5.35 | 5.3 | |||||
American Depositary Receipts Ratio (ADR) | 1 | 1 | 1 | 1 | 1 | |||||
Supplemental Items | ||||||||||
EBITDA | 2.04B | 2.27B | 3.43B | 5.65B | 6.18B | |||||
EBITA | 1.25B | 1.42B | 2.48B | 4.54B | 4.72B | |||||
EBIT | 1.18B | 1.34B | 2.39B | 4.43B | 4.62B | |||||
EBITDAR | 2.1B | 2.33B | 3.5B | 5.71B | 6.26B | |||||
Total Revenues (As Reported) | 9.56B | 10.22B | 12.76B | 16.13B | 17.29B | |||||
Effective Tax Rate - (Ratio) | 13.12 | 12.55 | 14.16 | 11.59 | 11.36 | |||||
Current Foreign Taxes | 131M | 171M | 285M | 510M | 528M | |||||
Total Current Taxes | 131M | 171M | 285M | 510M | 528M | |||||
Deferred Foreign Taxes | 25M | -12M | 46M | 10M | 13M | |||||
Total Deferred Taxes | 25M | -12M | 46M | 10M | 13M | |||||
Normalized Net Income | 742M | 815M | 1.45B | 2.81B | 2.99B | |||||
Interest on Long-Term Debt | 54M | 54M | 34M | 1M | 4M | |||||
Non-Cash Pension Expense | 24M | 16M | 11M | -2M | 20M | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 17M | 12M | 14M | 18M | 23M | |||||
Selling and Marketing Expenses | 17M | 12M | 14M | 18M | 23M | |||||
Research And Development Expense From Footnotes | 1.62B | 1.68B | 1.85B | 2.01B | 2.23B | |||||
Net Rental Expense, Total | 65M | 65M | 68M | 62M | 71M | |||||
Imputed Operating Lease Interest Expense | 13.41M | 11.02M | 8.22M | 2.28M | 10.27M | |||||
Imputed Operating Lease Depreciation | 51.59M | 53.98M | 59.78M | 59.72M | 60.73M | |||||
Stock-Based Comp., COGS (Total) | 22M | 25M | 34M | 34M | 40M | |||||
Stock-Based Comp., R&D Exp. (Total) | 77M | 79M | 70M | 69M | 71M | |||||
Stock-Based Comp., SG&A Exp. (Total) | 46M | 51M | 117M | 112M | 125M | |||||
Total Stock-Based Compensation | 145M | 155M | 221M | 215M | 236M |